Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
THERAVANCE BIOPHARMA INC
Ticker: TBPH
CUSIP: G8807B106
Class: Common Stock
DRIEHAUS CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000938206)
Note: Option positions (PUT/CALL) are excluded.
Q2 2017
Shares
32,666
Value ($000)
$1,301
Avg Close
$38.45
Range
$34.85 - $43.44
Q1 2017
Shares
33,533
Value ($000)
$1,235
Avg Close
$31.95
Range
$27.80 - $37.18
Period
Shares
Value ($000)
Average Close
Price Range
Q2 2017
32,666
$1,301
$38.45
$34.85 - $43.44
Q1 2017
33,533
$1,235
$31.95
$27.80 - $37.18